Unlock instant, AI-driven research and patent intelligence for your innovation.

Production method of anti-staphylococcus aureus genetically modified goat

A genetic modification, goat technology, applied in the field of genetic engineering, can solve problems such as poor prevention effect, no breakthrough, no long-term effect, etc.

Active Publication Date: 2021-10-15
CHINA AGRI UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the different environments, regions, and climates of goats, the immune effect of vaccines is often only short-term effective, without long-term effects, and the preventive effect is not good.
In response to this situation, relevant veterinary experts at home and abroad are also actively evaluating the immunization against dairy goat mastitis, aiming to develop a more effective vaccine against goat mastitis, but no breakthrough has been made so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Production method of anti-staphylococcus aureus genetically modified goat
  • Production method of anti-staphylococcus aureus genetically modified goat
  • Production method of anti-staphylococcus aureus genetically modified goat

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] Preparation of embodiment 1 TLR2-4 transgenic goat

[0076] 1. Preparation of TLR2-4 chimeric gene

[0077] Referring to the exon sequences of goat TLR2 and TLR4 in GenBank, two pairs of primers were designed and synthesized. The primer sequences are as follows:

[0078] TLR2 gene amplification primers:

[0079] Forward: 5'-GCCTCTGATCAGGCTTCTTC-3'

[0080] Reverse: 5'-CCTAGGACCTTATTGCAGCT-3'

[0081] TLR4 gene amplification primers:

[0082]Forward: 5'-ATCATCAGCGTGTCGGTTGT-3'

[0083] Reverse: 5'-TCAGGTGGAGGTGGTCGCTT-3'

[0084] Extract goat blood RNA, reverse transcribe and synthesize cDNA, use the above primers as a template, use the RT-PCR method to amplify goat TLR2 and TLR4 gene fragments, and use the following primers at the 5' end of the TLR2 exon A signal peptide and a Myc sequence were added, and a 20 bp TLR4 extracellular region homologous sequence was added to the 3' end of the TLR2 extracellular region exon.

[0085] Forward: ATGCCACGTGCTTTGTGGACAGCGT...

Embodiment 2

[0135] Example 2 RT-PCR Identification of Transgenic Goat TLR2-4 Chimeric Protein

[0136] RNA was extracted from peripheral blood macrophages of newborn lambs, and RT-PCR detection and WB detection were performed. The results showed that the cDNA of transgenic goat macrophages successfully amplified the TLR2-4 chimeric gene fragment. The PCR detection results are shown in Figure 5 . Primers are as follows:

[0137] Primer P1: (TLR2-4 chimeric gene amplification primer)

[0138] Forward: TGACTTCCTGTCCTTCACACA

[0139] Reverse: CTTTACCAGTTCATTCCGCA

[0140] Primer P2: (amplification primer for internal reference gene GAPDH)

[0141] Forward: CTGACCTGCCGCCTGGAGAAA

[0142] Reverse: GTAGAAGAGTGAGTGTCGCTGTT

[0143] The results showed that the site-specific integration of TLR2-4 chimeric gene and the expression of TLR2-4 chimeric protein had been successfully performed in transgenic goats.

Embodiment 3

[0144] Example 3 Identification of TLR2-4 gene-transferred goat macrophage phagocytosis ability of Staphylococcus aureus

[0145] FITC-labeled Staphylococcus aureus was used to infect TLR2-4 macrophages and goat macrophages of the WT control group at MOI=10 for 1 hour, and after washing with PBS three times, the cells were incubated with DMEM containing 200 μg / ml gentamicin for 1 hour. Remove bacteria adhering to the cell surface. The phagocytosis index (mean fluorescence intensity of FITC in macrophages) and phagocytosis rate (number of FITC-positive cells / total cytometry×100%) of cells in the two groups were detected by flow cytometry. Such as Figure 6 As shown, at 30 min, 60 min, and 120 min of infection, the phagocytic index of TLR2-4 macrophages on Staphylococcus aureus was significantly higher than that of wild-type goat macrophages in the two groups. Such as Figure 7 As shown, the phagocytosis rate of S. aureus by TLR2-4 macrophages was significantly higher than th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a production method of an anti-staphylococcus aureus genetically modified goat, in particular to a method of introducing a TLR2-4 chimeric gene (SEQ ID No.1) into somatic cells of a goat and regenerating a genetically modified goat from the transformed somatic cells, with the TLR2-4 chimeric gene comprising an extracellular region of a TLR2 gene, and a transmembrane region and an intracellular region of a TLR4 gene. According to the invention, a CRISPA / Cas9 system is used for site-specific integration of the TLR2-4 chimeric gene onto a first intron of a goat SETD5 gene, a somatic cell nuclear transfer technology is used for preparation of a transgenic goat expressing TLR2-4 chimeric protein, and the constructed transgenic goat has improved staphylococcus aureus resistance and enhanced immunity; the purpose of effectively preventing and controlling goat mastitis caused by staphylococcus aureus through innate immunity of goats is achieved, and a foundation is laid for the preparation of a novel anti-staphylococcus aureus goat germplasm.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering and relates to a method for producing genetically modified goats resistant to Staphylococcus aureus. It specifically relates to a method for expressing chimeric TLR2-4 genes in goat cells against Staphylococcus aureus. Background technique [0002] Goat mastitis is one of the most important diseases of goats caused by pathogenic bacteria. Bacteriological analysis showed that Staphylococcus aureus (S. aureus) was the most isolated bacteria from goat udder (40.5%). The clinical manifestations of the disease are obvious abnormalities in goat breasts, pain, abscess, fever, and a rapid decline in milk production, which will seriously affect the lactation function of goats, and acute mastitis may even cause death of goats. The disease is widespread worldwide and milk produced by affected goats poses a serious risk to public health as it may be associated with milk-borne disease in humans. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/85C12N15/62C12N15/113C12N15/90C07K19/00A01K67/027
CPCC12N15/8509C12N15/113C12N15/907C07K14/70596A01K67/0278C12N2310/20C07K2319/02C07K2319/41A01K2207/15A01K2217/072A01K2227/102A01K2267/02Y02A40/70
Inventor 韩红兵王梦瑶连正兴
Owner CHINA AGRI UNIV